147 related articles for article (PubMed ID: 20615056)
1. Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues.
Obulesu M; Rao DM
Int J Neurosci; 2010 Aug; 120(8):531-7. PubMed ID: 20615056
[TBL] [Abstract][Full Text] [Related]
2. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
[TBL] [Abstract][Full Text] [Related]
3. The association of aluminum Alzheimer's disease, and neurofibrillary tangles.
Perl DP; Good PF
J Neural Transm Suppl; 1987; 24():205-11. PubMed ID: 3316495
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mouse models of Alzheimer's disease: phenotype and application.
Higgins GA; Jacobsen H
Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic strategies and Alzheimer's disease: contribution of animal models].
Chabrier PE
Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893
[TBL] [Abstract][Full Text] [Related]
7. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy.
Götz J; Streffer JR; David D; Schild A; Hoerndli F; Pennanen L; Kurosinski P; Chen F
Mol Psychiatry; 2004 Jul; 9(7):664-83. PubMed ID: 15052274
[TBL] [Abstract][Full Text] [Related]
8. Searching for new animal models of Alzheimer's disease.
Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
[TBL] [Abstract][Full Text] [Related]
9. Modeling Alzheimer's disease in transgenic mice.
Duff K
J Fla Med Assoc; 1994 Sep; 81(9):625-8. PubMed ID: 7964589
[TBL] [Abstract][Full Text] [Related]
10. Neuropathologic, neurochemical and immunocytochemical characteristics of aluminum-induced neurofilamentous degeneration.
Pendlebury WW; Beal MF; Kowall NW; Solomon PR
Neurotoxicology; 1988; 9(3):503-10. PubMed ID: 3200512
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes.
MacDonald AB
Med Hypotheses; 2007; 68(4):822-5. PubMed ID: 17055667
[TBL] [Abstract][Full Text] [Related]
12. Animal models of amyloid-beta-related pathologies in Alzheimer's disease.
Philipson O; Lord A; Gumucio A; O'Callaghan P; Lannfelt L; Nilsson LN
FEBS J; 2010 Mar; 277(6):1389-409. PubMed ID: 20136653
[TBL] [Abstract][Full Text] [Related]
13. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
14. Learning and memory in transgenic mice modeling Alzheimer's disease.
Ashe KH
Learn Mem; 2001; 8(6):301-8. PubMed ID: 11773429
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease: Abeta, tau and synaptic dysfunction.
LaFerla FM; Oddo S
Trends Mol Med; 2005 Apr; 11(4):170-6. PubMed ID: 15823755
[TBL] [Abstract][Full Text] [Related]
16. Steps towards a mouse model of Alzheimer's disease.
Crowther RA
Bioessays; 1995 Jul; 17(7):593-5. PubMed ID: 7646481
[TBL] [Abstract][Full Text] [Related]
17. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
Savory J; Huang Y; Wills MR; Herman MM
Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
[TBL] [Abstract][Full Text] [Related]
18. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
19. Experimental aluminum encephalomyelopathy. Relationship to human neurodegenerative disease.
Rao JK; Katsetos CD; Herman MM; Savory J
Clin Lab Med; 1998 Dec; 18(4):687-98, viii. PubMed ID: 9891607
[TBL] [Abstract][Full Text] [Related]
20. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study.
Good PF; Perl DP; Bierer LM; Schmeidler J
Ann Neurol; 1992 Mar; 31(3):286-92. PubMed ID: 1637136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
